Imunon (IMNN) Non Operating Investment Income (2018 - 2019)
Imunon's (IMNN) quarterly Non Operating Investment Income came in at $58068.0 in Q3 2019, up 1982.78% YoY from $2788.0 in Q3 2018, and up 5892.57% on a QoQ basis from $969.0 in Q2 2019.
Imunon (IMNN) Non Operating Investment Income (2018 - 2019) Analysis & Trends
Imunon (IMNN) has 2 years of Non Operating Investment Income data on file, last reported at $58068.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 58,068.00 |
| Sep 30, 2019 | 58,068.00 |
| Jun 30, 2019 | 969.00 |
| Jun 30, 2019 | 969.00 |
| Mar 31, 2019 | 9,381.00 |
| Mar 31, 2019 | 9,381.00 |
| Sep 30, 2018 | 2,788.00 |
| Sep 30, 2018 | 2,788.00 |
| Jun 30, 2018 | 3,902.00 |
| Jun 30, 2018 | 3,902.00 |
| Mar 31, 2018 | 4,435.00 |
| Mar 31, 2018 | 4,435.00 |